Tolerating subretinal fluid in neovascular age-related macular degeneration treated with ranibizumab using a treat-and-extend regimen: FLUID study 24-month results - Guymer, R H; Markey, C M; McAllister, I L; FLUID Investigators (Ophthalmology, 2019)